Biggest News Aggregation in the World
📰 Stuart Mackey News

Stuart Mackey News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Stuart Mackey. Real-time updates on events, politics, business and more.

Daiichi Sankyo, Merck ink $22-billion cancer drug deal

The deal adds promising drug candidates to Mercks oncology portfolio, as its bestselling cancer therapy Keytruda will see its patent expire later this decade. A treatment that harnesses patients own immune system to fight cancer, Keytruda is also expected to enter US government drug price negotiations in 2028, when its set to reach $33 billion in global sales, about 45% of Mercks revenue that year.
Daiichi Sankyo Stuart Mackey Merck Co Daiichi Sankyo Co Astrazeneca Plc Breast Cancer

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science